{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Attention deficit disorder with hyperactivity", "Pharmacology", "Plants, medicinal", "Shichangpu (Rhizoma Acori Tatarinowii)"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32227770", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "01"}, "DateRevised": {"Year": "2021", "Month": "06", "Day": "01"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "2589-451X", "JournalIssue": {"Volume": "40", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Feb"}}, "Title": "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan", "ISOAbbreviation": "J Tradit Chin Med"}, "ArticleTitle": "Mechanism underpinning effects of Shichangpu (Rhizoma Acori Tatarinowii) on attention deficit hyperactivity disorder.", "Pagination": {"StartPage": "94", "EndPage": "102", "MedlinePgn": "94-102"}, "Abstract": {"AbstractText": ["To investigate the mechanism underlying the effects of Shichangpu (Rhizoma Acori Tatarinowii) on attention deficit hyperactivity disorder (ADHD).", "A network pharmacology approach integrating ingredients of Shichangpu (Rhizoma Acori Tatarinowii) and target with ADHD, network construction, molecular function interactions and pathway analysis was used.", "This approach successfully helped to identify 7 active ingredients of CN, interacting with 21 key targets (ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, PTGS1, SLC6A2, SLC6A3, SLC6A4, DRD1, DRD5, HTR2A, ADRA1D, MAOB, GRIA2, HTR1A). The molecular function interactions among candidate targets mainly consisted of four groups: G-protein coupled amine receptor activity, catecholamine binding, monoamine transmembrane transporter activity and neurotransmitter receptor activity. Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis indicated that Shichangpu (Rhizoma Acori Tatarinowii)-regulated pathways were mainly classified into signal transduction and monoamine neurotransmitters.", "Our investigation revealed that Shichangpu (Rhizoma Acori Tatarinowii) could improve the symptoms of ADHD by regulating neurotransmitter, in multiple types of compounds-target-pathway, which may be implicated in the major pathological processes of ADHD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China."}], "LastName": "Feng", "ForeName": "Kai", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China."}], "LastName": "Zhao", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China."}], "LastName": "Ren", "ForeName": "Xinxin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China."}], "LastName": "Chou", "ForeName": "Yiqian", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China."}], "LastName": "Yu", "ForeName": "Qingyang", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Chinese Medicine, Jinan 250355, China."}], "LastName": "Li", "ForeName": "Ling", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatrics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China."}], "LastName": "Wang", "ForeName": "Junhong", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "J Tradit Chin Med", "NlmUniqueID": "8211546", "ISSNLinking": "0255-2922"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Acorus"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Attention Deficit Disorder with Hyperactivity"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Molecular Targeted Therapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Rhizome"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32227770", "2995"]}}]}